Literature DB >> 24732022

Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations.

Sarah M Mercier1, Bas Diepenbroek1, Rene H Wijffels2, Mathieu Streefland3.   

Abstract

Increasingly elaborate and voluminous datasets are generated by the (bio)pharmaceutical industry and are a major challenge for application of PAT and QbD principles. Multivariate data analysis (MVDA) is required to delineate relevant process information from large multi-factorial and multi-collinear datasets. Here the key role of MVDA for industrial (bio)process data is discussed, with a focus on progress and limitations of MVDA as a PAT solution for biopharmaceutical cultivation processes. MVDA based models were proven useful and should be routinely implemented for bioprocesses. It is concluded that although the highest level of PAT with process control within its design space in real-time during manufacturing is not reached yet, MVDA will be central to reach this ultimate objective for cell cultivations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  biopharmaceutical industry; cell cultivation; process analytical technology; quality by design

Mesh:

Year:  2014        PMID: 24732022     DOI: 10.1016/j.tibtech.2014.03.008

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  14 in total

Review 1.  Monitoring Quality of Biotherapeutic Products Using Multivariate Data Analysis.

Authors:  Anurag S Rathore; Mili Pathak; Renu Jain; Gaurav Pratap Singh Jadaun
Journal:  AAPS J       Date:  2016-04-04       Impact factor: 4.009

Review 2.  Recent applications of chemometrics in one- and two-dimensional chromatography.

Authors:  Tijmen S Bos; Wouter C Knol; Stef R A Molenaar; Leon E Niezen; Peter J Schoenmakers; Govert W Somsen; Bob W J Pirok
Journal:  J Sep Sci       Date:  2020-03-19       Impact factor: 3.645

3.  Towards the Development of Digital Twins for the Bio-manufacturing Industry.

Authors:  Carina L Gargalo; Simoneta Caño de Las Heras; Mark Nicholas Jones; Isuru Udugama; Seyed Soheil Mansouri; Ulrich Krühne; Krist V Gernaey
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  Induced pluripotent stem cells in cartilage repair.

Authors:  Steven A Lietman
Journal:  World J Orthop       Date:  2016-03-18

Review 5.  Fluorescence spectroscopy and chemometric modeling for bioprocess monitoring.

Authors:  Saskia M Faassen; Bernd Hitzmann
Journal:  Sensors (Basel)       Date:  2015-04-30       Impact factor: 3.576

6.  Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study.

Authors:  Moritz von Stosch; Jan-Martijn Hamelink; Rui Oliveira
Journal:  Bioprocess Biosyst Eng       Date:  2016-02-15       Impact factor: 3.210

7.  Estimating Extrinsic Dyes for Fluorometric Online Monitoring of Antibody Aggregation in CHO Fed-Batch Cultivations.

Authors:  Karen Schwab; Friedemann Hesse
Journal:  Bioengineering (Basel)       Date:  2017-07-24

8.  Model Transferability and Reduced Experimental Burden in Cell Culture Process Development Facilitated by Hybrid Modeling and Intensified Design of Experiments.

Authors:  Benjamin Bayer; Mark Duerkop; Gerald Striedner; Bernhard Sissolak
Journal:  Front Bioeng Biotechnol       Date:  2021-12-23

Review 9.  Harnessing the potential of machine learning for advancing "Quality by Design" in biomanufacturing.

Authors:  Ian Walsh; Matthew Myint; Terry Nguyen-Khuong; Ying Swan Ho; Say Kong Ng; Meiyappan Lakshmanan
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 10.  Process Analytical Technologies and Data Analytics for the Manufacture of Monoclonal Antibodies.

Authors:  Murali K Maruthamuthu; Scott R Rudge; Arezoo M Ardekani; Michael R Ladisch; Mohit S Verma
Journal:  Trends Biotechnol       Date:  2020-08-21       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.